How to Value a Mental Health Practice in 2026

I've watched mental health M&A go from a sleepy backwater to one of the most active healthcare verticals in the span of five years. The numbers tell the story: our database of 186 mental health transactions shows a median of 10.0x EBITDA and 1.4x revenue, with deal flow accelerating every quarter. If you own a mental health practice with more than a handful of clinicians, there's almost certainly a buyer interested in talking to you right now.

But "interested" and "willing to pay what you think it's worth" are very different things. Mental health practice valuation is nuanced, and I've seen owners leave hundreds of thousands on the table because they didn't understand what buyers actually care about. Let me walk you through it.

The Solo vs. Group Practice Divide

This is the single most important distinction in mental health valuation, and it's not close. A solo therapist practice — even one generating $300K in revenue — is fundamentally a job, not a business. When you leave, the revenue leaves with you. Buyers know this, and they price accordingly.

For practices under $5M in enterprise value, we see multiples around 7.6x EBITDA and 0.75x revenue. But within that range, the spread is enormous. A solo practitioner might sell at 3-4x SDE (essentially buying a patient panel and a lease), while a group practice with 8-10 employed therapists, established referral relationships, and a clinical director who isn't the owner might command 8-10x EBITDA.

In the $5-25M range, multiples firm up to about 8.0x EBITDA and 0.9x revenue. At this size, you typically have enough scale that the business operates independently of any single clinician, including the owner. That's what buyers are paying for — a machine that generates clinical revenue without depending on one person's patient relationships.

If you're a solo practitioner wondering about your practice's value, I'd encourage you to read our piece on why owner dependency kills value. The dynamics apply with particular force in mental health, where the therapeutic relationship is deeply personal.

Why PE Firms Are Flooding Into Mental Health

Private equity discovered mental health around 2019, and the thesis hasn't changed: massive unmet demand, fragmented supply, favorable reimbursement trends, and telehealth scalability. Every PE firm I talk to has either built a mental health platform or is actively looking for one.

The numbers support the thesis. The SAMHSA estimates that over 50% of Americans with mental illness don't receive treatment, and employer mental health benefits have expanded dramatically post-COVID. Insurance parity laws continue to strengthen, and reimbursement rates for behavioral health services have been increasing 3-5% annually while many medical specialties see flat or declining rates.

What PE firms look for in a mental health platform acquisition:

• 15+ clinicians across multiple locations or a robust telehealth operation
• $3M+ revenue with demonstrated growth trajectory
• Clinical leadership that isn't the owner — a clinical director or senior therapist who manages quality and supervision
• Diversified payer mix — commercial insurance, Medicare, and some private-pay, with no single payer over 30%
• Credentialing infrastructure — established contracts with major payers that a new entrant would take 6-12 months to replicate

If your practice checks most of these boxes, you're in a seller's market. If you're missing several, you can still sell — but you're more likely looking at a strategic buyer (another practice) than a PE-backed platform.

Telehealth: The Valuation Game-Changer

Telehealth didn't just change how mental health services are delivered — it fundamentally altered the valuation math. Before telehealth, a practice's growth was constrained by office space. You could only see as many patients as you had therapy rooms and hours in the day. Telehealth removed that ceiling.

A practice that delivers 40-60% of sessions via telehealth is more valuable than an identical practice that's 100% in-person, for several reasons:

• Lower overhead per session: No office space needed for telehealth visits. A therapist working from home on telehealth days costs you nothing in real estate.
• Larger geographic reach: You can recruit therapists and serve patients across your entire state, not just your metro area.
• Higher clinician utilization: No-show rates for telehealth are typically 8-12% vs. 15-20% for in-person. That's a meaningful productivity gain.
• Scalability narrative: Buyers love the story that adding capacity means hiring another therapist and handing them a laptop, not signing another lease.

That said, practices that are 100% telehealth face their own valuation challenges. Buyers worry about patient stickiness (easier to switch when you've never been to a physical office), clinician retention (remote therapists have less loyalty), and regulatory risk (telehealth licensure rules remain state-specific and evolving). The sweet spot for valuation purposes is a hybrid model.

The ABA Therapy Phenomenon

Applied Behavior Analysis (ABA) therapy for autism spectrum disorder has become its own distinct PE consolidation wave. ABA providers have attracted more PE investment than any other mental health subspecialty, and for good reason: the economics are exceptional.

ABA therapy typically involves 20-40 hours per week of services per patient, delivered by Board Certified Behavior Analysts (BCBAs) and Registered Behavior Technicians (RBTs). Revenue per patient can reach $50,000-$100,000 annually. Insurance mandates in all 50 states require coverage, and demand far outstrips supply — most ABA providers have waitlists measured in months.

ABA-focused practices command premium multiples, often 10-14x EBITDA for well-run operations. The key value drivers are BCBA retention rates, patient census relative to capacity, payer contract rates, and the ratio of BCBAs to RBTs (which drives supervision efficiency and margins).

If you run an ABA practice, you're in one of the most active M&A markets in all of healthcare. But be thoughtful about timing — some acquirers have overpaid and are struggling with integration, which could cool the market.

Insurance Credentialing: The Hidden Asset

In my experience, mental health practice owners consistently undervalue their insurance credentialing. Getting paneled with major commercial payers — Aetna, Blue Cross, Cigna, UnitedHealthcare — takes 90-180 days per payer, per clinician. Some payers have closed panels in certain geographies, meaning new providers literally cannot get credentialed.

When a buyer acquires your practice, they acquire your payer contracts and your clinicians' credentialing. For a practice with 15 therapists credentialed across 6 major payers, that's 90 individual credentialing relationships that a buyer would need 12-18 months to replicate from scratch — if they could get approved at all.

This is a tangible, defensible asset. Make sure your credentialing records are organized and current. A buyer's due diligence team will want to verify every credentialing relationship, and gaps or lapses will reduce your valuation.

Private-Pay vs. Insurance-Based Models

Private-pay (out-of-pocket) mental health practices have an appeal: higher per-session rates ($150-$300 vs. $80-$150 from insurance), no claims processing, and no credentialing headaches. But in my experience, purely private-pay practices sell for lower multiples than insurance-based practices of the same size.

The reason is scalability. A private-pay practice is typically capped by the local market's ability to pay out-of-pocket rates. Insurance-based practices can grow much larger because the addressable market is 5-10x bigger. PE buyers in particular want insurance infrastructure because their growth playbook depends on adding clinicians and leveraging existing payer contracts across locations.

The exception is high-end executive or concierge mental health practices that can demonstrate consistent $500K+ per clinician revenue at premium rates. These are rare and attract a different buyer profile.

Maximizing Your Mental Health Practice Value

Based on the 186 transactions in our dataset and my own advisory experience, here's what moves the needle:

• Build beyond yourself: Hire clinicians, develop a clinical director role, create supervision structures. Every therapist you add who has their own patient panel makes the practice less dependent on you.
• Invest in credentialing: Get every clinician paneled with every major payer in your market. This is tedious work that pays off enormously at exit.
• Build telehealth infrastructure: Even if most of your sessions are in-person, having a working telehealth platform with demonstrated utilization shows buyers a scalable model.
• Track your metrics: Sessions per clinician per week, no-show rates, average reimbursement per session, patient retention rates. Buyers want data, and practices that can produce it get better offers.
• Diversify referral sources: If your primary referral source is your Psychology Today profile, that's a fragile business. Build relationships with PCPs, schools, EAPs, and other institutional referrers.

The Bottom Line

Mental health practice valuation in 2026 rewards scale, infrastructure, and independence from any single clinician. The broader medical practice valuation principles apply, but mental health has unique advantages: a growing market with structural supply shortages, favorable reimbursement trends, and telehealth economics that make scaling cheaper than almost any other clinical specialty. If you're building a group practice with these dynamics in mind, you're building something that buyers will compete to acquire.